Stockscreener 앱 받기
0.642
0.45%
0.0029
VolitionRX Ltd 주식(VNRX)의 최신 뉴스
What does recent volatility data suggest for VolitionRx LimitedReversal Pattern Insights with Entry Tips - Newser
Real time social sentiment graph for VolitionRx LimitedAI Enhanced Strategy for Portfolio Growth - Newser
How moving averages guide VolitionRx Limited tradingDaily Trade Setup Forecast with Confidence - Newser
Measuring VolitionRx Limited’s beta against major indicesStock Holding Strategy Long-Term Summary Sheet - Newser
What machine learning models say about VolitionRx LimitedBuy/Sell Zone Confirmation Technical Analysis - Newser
What risks could impact VolitionRx Limited stock performanceSwing Entry Insight With Forecast Accuracy - Newser
Visual analytics tools that track VolitionRx Limited performanceIntraday Strategy with Real Time Monitoring - Newser
Analyzing VolitionRx Limited with multi timeframe chartsDownside Control Plan With Support Analysis - Newser
Using AI based signals to follow VolitionRx LimitedEarly Buy Opportunity with Chart Triggers - Newser
VolitionRx Announces Pricing of $1.2 Million Registered Direct Offering - 富途牛牛
What makes VolitionRx Limited stock price move sharplyTrade Alert System with Volume Analysis - Newser
Is it the right time to buy VolitionRx Limited stockInvest smarter with expert stock recommendations - Jammu Links News
Volatility clustering patterns for VolitionRx LimitedTrend Reversal Probability Forecast Update - Newser
What are the technical indicators suggesting about VolitionRx LimitedSkyrocketing investment returns - Jammu Links News
What are analysts’ price targets for VolitionRx Limited in the next 12 monthsGet high-impact stock recommendations now - Jammu Links News
What is the dividend policy of VolitionRx Limited stockMarket Forecast Review For 2025 - Jammu Links News
Combining machine learning predictions for VolitionRx LimitedQuick Profit Setup with Signal Forecast - Newser
Automated trading signals detected on VolitionRx LimitedFree AI Driven Buy Alert Trade Blueprint - Newser
Applying big data sentiment scoring on VolitionRx LimitedInvestment Timeline and ROI Summary Report - Newser
VolitionRx Limited Rebounds From Oversold Zone — Now WhatSwing Trading Plan With Smart Signals in Review - metal.it
Short Term Charts Align With Long Term Uptrend in VolitionRx LimitedBuy Alerts With Low Risk Confirmation Noted - beatles.ru
When is VolitionRx Limited stock expected to show significant growthAdvanced Screener Data Feed To Watch Now - Jammu Links News
What markets is VolitionRx Limited expanding into Is FOXO stock a good long term investment optionMassive stock growth - Jammu Links News
What are the latest earnings results for VolitionRx LimitedGet alerts on the hottest market movers - Jammu Links News
How many analysts rate VolitionRx Limited as a “Buy”Unlock daily market insights for better trades - Jammu Links News
Does VolitionRx Limited stock perform well during market downturnsAchieve rapid wealth accumulation with smart picks - Jammu Links News
Should I hold or sell VolitionRx Limited stock in 2025Jaw-dropping returns - Jammu Links News
What is the risk reward ratio of investing in VolitionRx Limited stockAchieve breakthrough investment performance - Jammu Links News
Buy Signal for VolitionRx Limited Stock Key Technical Indicators to WatchBig Return Stock Tips - Newser
Why VolitionRx Limited stock attracts strong analyst attentionProtected Capital Trading Plan - metal.it
How VolitionRx Limited stock performs during market volatilityFree Access to Community - Newser
What analysts say about VolitionRx Limited stockFree Stock Selection - PrintWeekIndia
VolitionRx Limited Stock Analysis and ForecastOutstanding capital growth - Jammu Links News
What analysts say about BGSF stockUnmatched profit growth - jammulinksnews.com
Is VolitionRx Limited a good long term investmentSky-high profits - jammulinksnews.com
What drives VolitionRx Limited stock pricePowerful profit generation - jammulinksnews.com
Nu.Q® Discover Expands Global Adoption and Epigenetic Innovation - MarketScreener
VolitionRx Limited Announces Lateral Flow Test for Point-of-Care Quantification of Nucleosomes - MarketScreener
Breakthrough: New 5-Minute Blood Test Could Transform Emergency Care and Sepsis Detection - Stock Titan
Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes - Ariva
VolitionRx:Nu.Q advances in lung cancer management - research-tree.com
VNRX INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of VolitionRx Ltd. (NYSE: VNRX) and Encourages Long-Term Investors to Contact the Firm - ACCESS Newswire
VolitionRx CEO Cameron Reynolds acquires $7,372 in common stock By Investing.com - Investing.com India
1.15%
자본화:
|
볼륨(24시간):